| Pbrm1 steers mesenchymal stromal cell osteolineage differentiation by integrating PBAF-dependent chromatin remodeling and BMP/TGF-β signaling S Sinha, M Biswas, SS Chatterjee, S Kumar, A Sengupta Cell reports 31 (4), 2020 | 28 | 2020 |
| KDM6 demethylases integrate DNA repair gene regulation and loss of KDM6A sensitizes human acute myeloid leukemia to PARP and BCL2 inhibition LD Boila, S Ghosh, SK Bandyopadhyay, L Jin, A Murison, AGX Zeng, ... Leukemia 37 (4), 751-764, 2023 | 6 | 2023 |
| Spliceosome mutant myeloid malignancies are preferentially sensitive to PARP inhibition DH Nguyen, ZS Liu, S Sinha, M Bannister, E Arriaga-Gomez, A Song, ... Blood 138, 322, 2021 | 6 | 2021 |
| Emerging trends in chromatin remodeler plasticity in mesenchymal stromal cell function S Chakraborty, S Sinha, A Sengupta The FASEB Journal 35 (1), e21234, 2021 | 6 | 2021 |
| SWI/SNF subunit expression heterogeneity in human aplastic anemia stem/progenitors S Sinha, SS Chatterjee, M Biswas, A Nag, D Banerjee, R De, A Sengupta Experimental hematology 62, 39-44. e2, 2018 | 6 | 2018 |
| Establishment of a long-term co-culture assay for mesenchymal stromal cells and hematopoietic stem/progenitors S Sinha, S Chakraborty, A Sengupta STAR protocols 1 (3), 100161, 2020 | 2 | 2020 |
| Therapeutic targeting of spliceosome mutant myeloid neoplasms via PARP1 inhibition S Sinha, ZS Liu, M Bannister, E Arriaga-Gomez, A Song, D Zong, ... Blood 140 (Supplement 1), 217-219, 2022 | 1 | 2022 |
| KDM6A loss sensitizes human acute myeloid leukemia to PARP and BCL2 inhibition LD Boila, S Ghosh, SK Bandyopadhyay, L Jin, A Murison, AGX Zeng, ... bioRxiv, 2022.07. 12.498585, 2022 | 1 | 2022 |
| miRNA and Cancer: A Deadly Liaison? S Sinha, LD Boila, SS Chatterjee, A Sengupta Cancer and Noncoding RNAs, 27-46, 2018 | 1 | 2018 |
| R-Loop Accumulation in Spliceosome Mutant Leukemias Confers Sensitivity to PARP1 Inhibition by Triggering Transcription–Replication Conflicts ZS Liu, S Sinha, M Bannister, A Song, E Arriaga-Gomez, AJ McKeeken, ... Cancer Research 84 (4), 577-597, 2024 | | 2024 |
| PARP inhibitors preferentially sensitize splicing factor mutant myeloid neoplasms DH Nguyen, S Sinha, ZS Liu, MH Bannister, E Arriaga-Gomez, A Song, ... Cancer Research 83 (7_Supplement), 6183-6183, 2023 | | 2023 |
| KDM6 Demethylases Integrate DNA Repair Gene Regulation: Loss of KDM6A Sensitizes AML to PARP Inhibition and Potentiates with BCL2 Blockade LD Boila, L Jin, A Murison, SK Bandyopadhyay, S Ghosh, ... Blood 138, 25, 2021 | | 2021 |
| UTX and MBD3 Epistasis Regulates Rac Gtpase Activation and Sensitizes Human Acute Myeloid Leukemia Cells to Dock Inhibition SS Chatterjee, M Biswas, LD Boila, S Chakraborty, S Sinha, D Banerjee, ... Blood 132, 3880, 2018 | | 2018 |
| Altered Expression of IARS (isoleucyl-tRNA synthetase) Genes in Leukemia S Mitra, A Samadder, S Sinha, A Sengupta, J Chakrabarti Clinical Lymphoma, Myeloma and Leukemia 16, S119, 2016 | | 2016 |
